CNS Clinical Trials : Suicidality and Data Collection: Workshop Summary PDF
by Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders
Edited by Bruce Altevogt, Miriam Davis, Sarah Hanson
Description
The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.
Information
-
Download - Immediately Available
- Format:PDF
- Pages:88 pages
- Publisher:National Academies Press
- Publication Date:22/12/2010
- Category:
- ISBN:9780309148849
Other Formats
- Paperback / softback from £13.15
- EPUB from £18.35
Information
-
Download - Immediately Available
- Format:PDF
- Pages:88 pages
- Publisher:National Academies Press
- Publication Date:22/12/2010
- Category:
- ISBN:9780309148849